Articles with public access mandates - David Moher - Heart and Stroke Foundation of CanadaLearn more
OverallCIHRCancer Research UKNIHRMRCNIHNSERCWellcomeNHMRCARCEuropean CommissionSNSFFRQSArnold Ventures LLCGovernment of SpainUK Research & InnovationANRESRCINSERMHRBPCORINational Centre for the Replacement, Refinement and Reduction of Animals in Research, UKHealth Data Research, UKZonMwNSFCGovernment of ItalyHSFSSHRCDFGVersus Arthritis, UKEPSRCGatesVAHHMIGenome CanadaMTANWOKnut and Alice Wallenberg FoundationBHFCSODFIDDiabetes UKMSFHRBMBFNKFIMedical Research Future Fund, AustraliaCZI
Available based on mandate: 2
Evaluating mesenchymal stem cell therapy for sepsis with preclinical meta-analyses prior to initiating a first-in-human trial
MM Lalu, KJ Sullivan, SHJ Mei, D Moher, A Straus, DA Fergusson, ...
Elife 5, e17850, 2016
Assessment of safety and efficacy of mesenchymal stromal cell therapy in preclinical models of acute myocardial infarction: a systematic review protocol
CC Barron, MM Lalu, DJ Stewart, D Fergusson, H Yang, D Moher, P Liu, ...
Systematic Reviews 6, 1-8, 2017
Publication and funding information is determined automatically by a computer program